Evidence map›Paper›PMID 33730589›Full record

ArticleCell reports2021

COX2 regulates senescence secretome composition and senescence surveillance through PGE

Susana Gonçalves, Kelvin Yin, Yoko Ito, Adelyne Chan, Ioana Olan, Sarah Gough, Liam Cassidy, Eva Serrao, Stephen Smith, Andrew Young and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer's disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Prostaglandin EAging · 2024
    Article
  19. Role of exosome-derived miRNAs in diabetic wound angiogenesis.Molecular and cellular biochemistry · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 3 countries.

Susana GonçalvesCRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Kelvin YinCRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Yoko ItoCRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Adelyne ChanCRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Ioana OlanCRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Sarah GoughCRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Liam CassidyCRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Eva SerraoCRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Stephen SmithDepartment of Pathology, University of Cambridge, Cambridge CB2 1QP, UK.
Andrew YoungCRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Masashi NaritaCRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK; Tokyo Tech World Research Hub Initiative (WRHI), Institute of Innovative Research, Tokyo Institute of Technology, Yokohama, Kanagawa 226-0026, Japan.
Matthew HoareCRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK; Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK. Electronic address: mwh20@cam.ac.uk.
University of Cambridge · GBTokyo Institute of Technology · JP

Funding

Biotechnology and Biological Sciences Research Council BB/S013466/1Cancer Research UK 15890Cancer Research UK 19924Cancer Research UK 24453Cancer Research UK 26813Cancer Research UK 29681Cancer Research UK 30462Cancer Research UK C52489/A19924Cancer Research UK C9545/A29580Medical Research Council MR/R010013/1
6 · The paper itself

Abstract

Senescent cells trigger their own immune-mediated destruction, termed senescence surveillance. This is dependent on the inflammatory senescence-associated secretory phenotype (SASP), which includes COX2, an enzyme with complex roles in cancer. The role COX2 plays during senescence surveillance is unknown. Here, we show that during RAS-induced senescence (RIS), COX2 is a critical regulator of SASP composition and senescence surveillance in vivo. COX2 regulates the expression of multiple inflammatory SASP components through an autocrine feedback loop involving its downstream product, prostaglandin E2 (PGE

Indexed as

Cellular SenescenceSecretomeAnimalsCyclooxygenase 2Cyclooxygenase 2 InhibitorsDinoprostoneFemaleFibroblastsHumansMiceMice, Inbred C57BLReceptors, Prostaglandin E, EP4 SubtypeSenescence-Associated Secretory PhenotypeTumor MicroenvironmentUp-RegulationCyclooxygenase 2Cyclooxygenase 2 InhibitorsDinoprostoneReceptors, Prostaglandin E, EP4 SubtypeCOX2immune surveillanceliverSASPsenescence

Identifiers

PMID33730589
PMCPMC7972992
OpenAlexW3136839549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.